基于DDQN的最佳向疗法,使用可逆抑制剂来对抗华堡效应
Jose M Sanz Nogales1, Juan Parras1, Santiago Zazo1
1Information Processing and Telecommunications Center, Universidad Politécnica de Madrid, ETSI Telecomunicación, Av. Complutense 30, 28040 Madrid, Spain.
Mathematical biosciences
|July 6, 2023
概括
这项研究使用三种细胞表型来模拟华堡效应,揭示了乳酸作为预后不良的指标. 它还使用强化学习开发了针对攻击性瘤的最佳向疗法.
科学领域:
- 在癌症生物学中的代谢重编程.
- 计算瘤学是一种计算瘤学.
- 瘤生态系统的进化建模.
背景情况:
- 沃伯格效应描述了癌细胞的新陈代谢变化,甚至在有氧的情况下也有利于糖解.
- 瘤异质性涉及不同的代谢表型,影响治疗耐药性.
- 一些瘤细胞产生的乳酸可以为其他瘤细胞提供燃料,有助于攻击性生长.
研究的目的:
- 开发一个Warburg效应的三组分进化模型.
- 了解代谢变化及其对侵袭性瘤的临床影响.
- 使用计算方法设计一种最佳的,个性化的向治疗方法.
主要方法:
- 一个模拟不同代谢表型的三组分进化模型 (糖溶性,乳酸利用,氧化酸化).
- 分析临床试验数据,特别是结直肠癌.
- 训练双深Q网络 (DDQN) 强化学习算法,以实现最佳的治疗设计.
- 根据汉密尔顿-雅各比-贝尔曼方程对DDQN衍生疗法的验证.
主要成果:
- 该模型复制了对侵袭性瘤的临床观察结果,并确定乳酸盐是不良的预后标记物.
- 乳酸酸促进瘤异质性,使治疗策略复杂化.
- 该DDQN算法产生了最佳的向疗法,考虑到患者的生活质量,药物剂量和禁忌.
- 在疗法得到了验证,证明了计算可行性.
结论:
- 沃伯格效应是由瘤内的不同相互作用的代谢表型驱动的.
- 乳酸是瘤进展和治疗耐药性的关键因素.
- 强化学习为开发个性化,最佳的癌症疗法提供了一种强有力的方法.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
siRNA - Small Interfering RNAs
16.9K
Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.9K


